These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8983902)

  • 1. [Chronic myeloproliferative diseases. Erythrocyte apheresis in polycythemia vera].
    Kaboth U; Rumpf KW; Hiddemann W; Kaboth W
    Dtsch Med Wochenschr; 1996 Nov; 121(47):1483. PubMed ID: 8983902
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebral Hemorrhage of a 50-Year-Old Female Patient with Polycythemia Vera.
    Chen L; Xiao H; Hu Z
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):e110-e112. PubMed ID: 31126786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Erythron in patients with polycythemia vera during treatment by erythrocytapheresis and bloodletting].
    Gudim VI; Sarycheva TG; Kotel'nikov VM; Melikian AL; Ivanova VS
    Ter Arkh; 1987; 59(6):48-51. PubMed ID: 3629498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Erythrocytapheresis in patients with secondary polyglobulia].
    Kessler P
    Vnitr Lek; 2004 Sep; 50(9):682-4. PubMed ID: 15580902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physiological methods of treatment of patients with polycythemia vera].
    Neustroev GV
    Ter Arkh; 1985; 57(7):54-9. PubMed ID: 2931850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of polycythemia vera].
    Lengfelder E; Hehlmann R
    Dtsch Med Wochenschr; 2001 Apr; 126(14):415. PubMed ID: 11332247
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic modification of polycythemia vera by transferred anti-erythrocyte antibodies].
    Hrubisko M; Fábryová L; Lipsic T
    Haematologia (Budap); 1973; 7(1):25-33. PubMed ID: 4146768
    [No Abstract]   [Full Text] [Related]  

  • 8. Neocytoapheresis in the treatment of polycythemia vera.
    Centurioni R; Leoni P; Candela M; Cristina Refe M; Stella Strusi A; Fabietti L; Danieli G
    Recenti Prog Med; 1996 Apr; 87(4):161-3. PubMed ID: 8643877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperviscosity in polycythemia vera and other red cell abnormalities.
    Kwaan HC; Wang J
    Semin Thromb Hemost; 2003 Oct; 29(5):451-8. PubMed ID: 14631544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential thrombocythemia following polycythemia vera: an unusual sequence.
    Randi ML; Barbone E; Zerbinati P; Soini B; Rossi C; Girolami A
    J Med; 1996; 27(5-6):363-8. PubMed ID: 9151204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic cytapheresis].
    Wiebecke D; Gunzer U; Ullrich H; Kadar J
    Beitr Infusionsther; 1991; 28():226-32. PubMed ID: 1725627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycythemia vera in dogs.
    McGrath CJ
    J Am Vet Med Assoc; 1974 Jun; 164(11):1117-22. PubMed ID: 4857967
    [No Abstract]   [Full Text] [Related]  

  • 13. [Quantity and rate of erythrocyte sedimentation in polycythemia vera and symptomatic erythrocytosis].
    Shulaeva EV; Shupik EI; Gritsenko LA
    Vrach Delo; 1978 Dec; (12):54-6. PubMed ID: 741725
    [No Abstract]   [Full Text] [Related]  

  • 14. Polycythemia vera.
    Stuart BJ; Viera AJ
    Am Fam Physician; 2004 May; 69(9):2139-44. PubMed ID: 15152961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chalone content of the blood of polycythemia vera patients following bloodletting].
    Neustroev GV; Melikian AL; Kovaleva LG; Blazhko OB
    Gematol Transfuziol; 1986 Jun; 31(6):3-6. PubMed ID: 2942440
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of therapy on causes of death in polycythemia vera.
    Wasserman LR; Balcerzak SP; Berk PD; Berlin NI; Donovan PB; Dresch C; Ellis JT; Goldberg JD; Landaw SA; Laszlo J; McIntyre OR; Najean Y; Pisciotta AV; Silverstein MN; Tartaglia AP; Tatarsky I; Weinfeld A
    Trans Assoc Am Physicians; 1981; 94():30-8. PubMed ID: 7344226
    [No Abstract]   [Full Text] [Related]  

  • 17. [Myeloproliferative syndrome of the polycythemia vera type].
    Lorz B
    Praxis (Bern 1994); 1998 Dec; 87(50):1763-5. PubMed ID: 9889589
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood rheologic disorders in patients with polycythemia vera and their correction by therapeutic erythrocytapheresis].
    Likhovetskaia ZM; Prigozhina TA; Gorbunova NA; Kalinin NN; Petrov MM
    Gematol Transfuziol; 1989 Nov; 34(11):33-6. PubMed ID: 2612862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic myeloproliferative diseases. 2: Polycythemia vera rubra].
    Zankovich R
    Fortschr Med; 1989 Nov; 107(33):717-9. PubMed ID: 2599496
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic erythroapheresis: Experience in patients with polycythemia vera and secondary erythrocytosis.
    Parra Salinas I; Recasens Flores V; Montañés MÁ; García-Erce JA
    Med Clin (Barc); 2020 Jan; 154(1):16-19. PubMed ID: 30795904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.